NCT00763087

Brief Summary

The purpose of this study is to determine if people with Diabetes Mellitus and peripheral neuropathy can increase their activity (i.e. walking or stationary biking) and leg strength without having an increase in foot problems compared to a group of people with diabetes and peripheral neuropathy that do no exercise. Our hypothesis is that the weight-bearing exercise group will achieve greater increases in weight-bearing activity (i.e., increased steps/day and cumulative load) and leg strength compared to the non-weight bearing exercise group and the non-exercising control group; and there will be no clinically meaningful difference in incidence or indicators of foot lesions between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
Completed

Started Sep 2008

Typical duration for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

September 26, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 30, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

November 7, 2017

Status Verified

November 1, 2017

Enrollment Period

2.3 years

First QC Date

September 26, 2008

Last Update Submit

November 3, 2017

Conditions

Keywords

diabetes mellitusperipheral neuropathyexercise

Outcome Measures

Primary Outcomes (1)

  • daily step count

    3 months

Secondary Outcomes (1)

  • skin breakdown

    3 months

Study Arms (3)

nonweightbearing exercise

ACTIVE COMPARATOR
Behavioral: nonweightbearing exercise

nonexercising control

PLACEBO COMPARATOR
Behavioral: nonexercising control

weightbearing exercise

EXPERIMENTAL
Behavioral: weightbearing exercise

Interventions

All subjects in the exercise group will participate, as able, in 3 supervised 1 hour exercise sessions per week for the first month and 2 supervised and 1 unsupervised exercise session per week for the remaining 2 months. Subjects in each exercise group will be seen on alternating times to avoid cross contamination of treatment intervention. Walking intensity for all subjects will be applied with the intent to exceed their routine physical stress level, and therefore incur positive adaptations to physical stress, but not exceed their threshold for injury.

weightbearing exercise

All subjects in the 2 exercise groups will participate, as able, in 3 supervised 1 hour exercise sessions per week for the first month and 2 supervised and 1 unsupervised exercise session per week for the remaining 2 months. Subjects in each exercise group will be seen on alternating times to avoid cross contamination of treatment intervention. Biking intensity for all subjects will be applied with the intent to exceed their routine physical stress level, and therefore incur positive adaptations to physical stress, but not exceed their threshold for injury.

nonweightbearing exercise

All subjects will be instructed, verbally and with written documents, regarding appropriate foot and skin care twice per month.

nonexercising control

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 or Type 2 DM and PN
  • biothesiometer \> 25mV and
  • unable to sense the 5.07 Semmes Weinstein monofilament on at least one spot on the plantar foot
  • Relatively sedentary
  • step count of 2-9,000 steps per day
  • exercising less than 3 times per week (\<20 min/session).
  • Have the approval of his/her primary care physician to participate in the study.

You may not qualify if:

  • Subjects who weigh greater than 300 pounds (DXA scanner's weight limit).
  • A history of severe foot deformity, such as Charcot neuroarthropathy or partial foot amputation that would require custom therapeutic footwear.
  • Any co-morbidity or medication that would interfere with ability to exercise according to ADA and ACSM guidelines.
  • People with severe depression as determined by the Beck Depression Inventory II with a score of 29 or greater.
  • People who are physically incapable of tolerating one hour of activity.
  • Women of child bearing age due to risk of exposure from radiation in DXA testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Program in Physical Therapy, Washington University in St. Louis

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Diabetes MellitusPeripheral Nervous System DiseasesMotor Activity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesNeuromuscular DiseasesNervous System DiseasesBehavior

Study Officials

  • Michael J Mueller, PT, PhD

    Washington University in St. Louis, Program in Physical Therapy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2008

First Posted

September 30, 2008

Study Start

September 1, 2008

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

November 7, 2017

Record last verified: 2017-11

Locations